Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael B Atkins, MD
Georgetown University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Diego
La Jolla, California, United States
- Yale University, Yale Cancer Center
New Haven, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber - Partners Cancer Care, Inc
Boston, Massachusetts, United States
- John Theurer Cancer Center
Hackensack, New Jersey, United States
- Cornell University
Ithaca, New York, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Penn Medicine Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Sept 2023
- Primary completion
- 10 Nov 2026
- Completion
- 10 Nov 2027
- Last update posted
- 11 Feb 2026
- Registered enrollment
- 120
- Registry id
- NCT05928806
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.